Publications
Here you will find the latest scientific publications related to the studies and research conducted by Santé publique France.
209 publications
article
A Comparative Study of the Prevalence of Hepatitis B and C Among Individuals Newly Diagnosed with Hepatocellular Carcinoma in Metropolitan France and in the Overseas Departments and Regions, 2015–2019
magazines/revues
Weekly Epidemiological Bulletin, February 8, 2022, No. 3-4 Hepatitis B, C, and Delta: From Epidemiological Data to Recommendations for Elimination
article
SurCeGIDD Surveillance: Screening and Diagnosis of HIV, Hepatitis B and C, and Bacterial STIs in CeGIDD in 2020
article
Screening and diagnosis of HIV, hepatitis B and C, and bacterial STIs at CeGIDD in 2018: individual data from the SurCeGIDD surveillance system
magazines/revues
Weekly Epidemiological Bulletin, November 24, 2020, No. 31-32 Screening and Management of Hepatitis B and C and Their Complications
article
Is the elimination of chronic viral hepatitis a reasonable goal by 2030?
article
2019 "Montpellier Without Hepatitis C" Universal Screening Campaign: Description and Evaluation
article
Prevention of mother-to-child transmission of the hepatitis B virus in France. 2016 National Perinatal Survey
article
Epidemiology of blood donors infected with HBV and HCV and the residual risk of transmission of these infections through transfusion in France, 1992–2018
article
Prevalence of risk factors for hepatocellular carcinoma in France in 2017: a study based on the linkage of data from the National Health Data System
In relation to
Hepatitis C
thematic dossier
Hepatitis C is a viral infection primarily transmitted through blood. Screening for the disease is crucial to ensuring that infected individuals receive the treatments that can now lead to a cure.
HIV/AIDS
thematic dossier
HIV, or Human Immunodeficiency Virus, is a sexually transmitted human retrovirus. It weakens the immune system, and if left untreated, leads to AIDS.
Vaccination
thematic dossier
Contagious diseases most often affect children at a very young age. Because children are particularly vulnerable, they are a priority target for vaccination programs.
